Drug reference
bbibp-corv
inactivated virus vaccine · vaccine
inactivated virus vaccinevaccine
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
BBIBP-CorV contains inactivated coronavirus (inactivated with β-propiolactone) which prevents viral replication but preserves all viral proteins. When injected, these inactivated viral particles are taken up by antigen-presenting cells (APCs) that present coronavirus proteins, resulting in an immune response.
Indications
prevention of severe or fatal COVID-19
Dosing
- Adult
- injected in two doses 21 days apart
Related guidelines
Other inactivated virus vaccine drugs
Ask House about bbibp-corv
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10